Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Clinical and Experimental Pharmacology & Physiology|November 9, 2000
Vasopressin V1a receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the ratT B Fraser, S W Turner, C Wen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Thiazolidinediones and congestive heart failure--exacerbation or new onset of left ventricular dysfunction?P M Srivastava, P Calafiore, R J MacIsaac, et al.
The Journal of Endocrinology|August 1, 1993
Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the ratL M Burrell, P A Phillips, J Stephenson, et al.
Journal of Computer Assisted Tomography|January 1, 1986
MR imaging of xanthogranulomatous pyelonephritisG P Mulopulos, S K Patel, D Pessis
Alimentary Pharmacology & Therapeutics|January 7, 2012
Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tractM Garg, P W Angus, L M Burrell, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the ratL M Burrell, R Chan, P A Phillips, et al.
Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology|April 6, 2004
Neural response to bird's own song and tutor song in the zebra finch field L and caudal mesopalliumN Amin, J A Grace, F E Theunissen
Hypertension (Dallas, Tex. : 1979)|November 1, 1995
Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonismL M Burrell, P A Phillips, J Risvanis, et al.
The American Journal of Physiology|August 5, 1998
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the ratL M Burrell, P A Phillips, J Risvanis, et al.
Pageof 15